China PTCA Balloon Market Investment Report, 2014-2016
  • Sep.2014
  • Hard Copy
  • USD $2,500
  • Pages:114
  • Single User License
    (PDF Unprintable)       
  • USD $2,350
  • Code: ZLC008
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,700
      

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI.

As national economy develops and people’s living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis.

Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China’s demand for PTCA balloon will hit 1.824 million sets by 2016.

At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009.

Local Chinese PTCA balloon companies include Lepu Medical, MicroPort, JW Medical, Yinyi, Neich Medical (Shenzhen), Synexmed, Sino Medical and Demax Medical, of which Lepu Medical, MicroPort, Neich Medical (Shenzhen) and Sino Medical manufacture both PTCA balloon catheter for delivering coronary stent and PTCA balloon, JW Medical manufactures only PTCA balloon for delivering coronary stent, and Demax Medical produces only PTCA balloon.

MicroPort is a bellwether in the Chinese coronary stent system market. On Jan. 20, 2014, MicroPort announced that it would acquire drug-eluting stent-related assets of Cordis under Johnson & Johnson. After the acquisition is completed, MicroPort’s share in drug-eluting stent market will rise by over 10%. This will also promote company’s business development of PTCA balloon for delivering coronary stent. MicroPort now can manufacture more than 200,000 sets of PTCA balloon annually.

Lepu Medical is a leading player in China PTCA balloon industry. The company now has PTCA balloon dilatation catheter capacity of 100,000 sets and coronary stent delivery system capacity of 170,000 sets.

冠脉 英文_副本.jpg

China PTCA Balloon Catheter Market Investment Report, 2014-2016 focuses on the following:
20120114.gifOperating environment of the Chinese PTCA balloon market, including macro environment, policy climate, medical & health care level and status quo of China medical device industry;
20120114.gifOverview of the Chinese PTCA balloon market, covering status quo, development bottlenecks, supply & demand, competitive landscape and development outlook and forecast;
20120114.gifInvestment in the Chinese PTCA balloon market, including favorable and unfavorable factors, economic benefit and site selection of plants;
20120114.gifOperation and PTCA balloon business of 5 foreign and 9 Chinese PTCA balloon companies.

1. Concepts Related to PTCA Balloon Industry
1.1 Definition and Classification of PTCA Balloon
1.2 Definition and Classification of Interventional Medical Device
  
2. Operating Environment of Chinese PTCA Balloon Market 
2.1 Macro Environment
2.2 Policy Climate
2.3 Medical & Health Care Level
2.4 Status Quo of China Medical Device Industry

3. Overview of Chinese PTCA Balloon Market
3.1 Status Quo
3.2 Development Bottleneck
3.3 Supply & Demand
3.3.1 Demand
3.3.2 Supply 
3.4 Competitive Landscape
3.5 Development Outlook and Forecast

4. Investment in Chinese PTCA Balloon Market
4.1 Favorable Factors
4.1.1 Strong Support by National Industrial Policy
4.1.2 Financial Incentives
4.1.3 Expanding Market Demand
4.1.4 Increasingly Standardized Market
4.2 Unfavorable Factors
4.2.1 Mounting Risk of Price Drop
4.2.2 Shortage of Related Production Materials and Equipment
4.2.3 Foreign Non-Tariff Barriers
4.3 Economic Benefit
4.4 Site Selection of Plants
4.4.1 Chengdu
4.4.2 Hangzhou
4.5 Construction of GMP Plant

5. Major Chinese Companies
5.1 Lepu Medical
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 PTCA Balloon Business
5.1.6 R&D and Investment
5.1.7 Forecast and Outlook
5.2 MicroPort
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 PTCA Balloon Business
5.2.5 R&D and Investment
5.2.6 Forecast and Outlook
5.3 JW Medical
5.3.1 Profile
5.3.2 PTCA Balloon Business
5.4 Dalian Yinyi
5.4.1 Profile
5.4.2 PTCA Balloon Business
5.5 Neich Medical (Shenzhen)
5.5.1 Profile
5.5.2 PTCA Balloon Business
5.6 SCW Medicath
5.6.1 Profile
5.6.2 PTCA Balloon Business
5.7 Synexmed
5.7.1 Profile
5.7.2 PTCA Balloon Business
5.8 Sino Medical
5.8.1 Profile
5.8.2 PTCA Balloon Business
5.9 Demax Medical (Beijing)
5.9.1 Profile
5.9.2 PTCA Balloon Business

6. Major Foreign Companies
6.1 Medtronic
6.1.1 Profile
6.1.2 Operation
6.1.3 PTCA Balloon Business
6.1.4 Operation in China
6.2 Boston Scientific
6.2.1 Profile
6.2.2 Operation
6.2.3 PTCA Balloon Business
6.2.4 Operation in China
6.3 Abbott
6.3.1 Profile
6.3.2 Operation
6.3.3 PTCA Balloon Business
6.3.4 Operation in China
6.4 Terumo
6.4.1 Profile
6.4.2 Operation
6.4.3 PTCA Balloon Business
6.4.4 Operation in China
6.5 B. Braun Melsungen
6.5.1 Profile
6.5.2 Operation
6.5.3 PTCA Balloon Business
6.5.4 Operation in China

Main Devices Used for PCI
OTW Balloon Catheter Diagram
Monorail/Rapid Exchange Balloon Catheter Diagram
Classification of Interventional Medical Device
China’s GDP and YoY Growth Rate, 1985-2013
Health Costs and % of GDP in China, 1980-2013
Per Capita Health Costs and YoY Growth Rate in China, 2006-2013E
Number of People 65 and Over and % of Total Population in China, 2004-2013
Laws and Regulations about Medical Device Industry in China
Industry Policies Concerning PTCA Balloon Industry
Number of Medical Institutions and Sickbeds in China, 2012-2013
Medical Service Quantity of Health Care Facilities in China, 2012-2013
Usage of Sickbeds in China’s Medical Institutions, 2012-2013
Total Industrial Output Value and YoY Growth Rate of China Medical Device Industry, 2005-2013E
Sales and YoY Growth Rate of China Medical Device Industry, 2005-2013E
Market Share of Home-made Coronary Drug-eluting Stent System in China, 2009-2013
Number of PCI Cases and Growth Rate in China, 2011-2013
Coronary Stent Implantation and Usage Percentage of Drug-eluting Stent in China, 2011-2013
China’s Demand for PTCA Balloon, 2011-2013
Major Coronary Stent System Brands and Their Market Shares in China (by Consumption), 2013
Market Share Comparison between Home-made and Imported PTCA Balloon, 2013
Number of PCI Cases and Growth Rate in China, 2011-2016E
Local Regulations on Circulation and Usage of Interventional Medical Devices
Market Prices of Major PTCA Balloon Catheter Brands in China, 2008/2013E
Operating Revenue and Total Profit of Artificial Limb, Artificial Organ and Interventional Medical Device Manufacturing, 2009-2014
Chengdu’s GDP and YoY Growth Rate, 2009-2013
Chengdu’s GDP and Percentage by Industry, 2013
Chengdu’s Total Fixed Asset Investment and YoY Growth, 2009-2013
Chengdu’s Total Fixed Asset Investment Breakdown by Industry, 2013
Actual Use of Foreign Direct Investment and YoY Growth in Chengdu, 2009-2013
Chengdu’s Total Industrial Output Value and YoY Growth, 2009-2013
Chengdu’s Industrial Value Added and YoY Growth, 2009-2013
Chengdu’s Industrial Value Added by Sector and Percentage, 2013
Average Wage of Employees in Chengdu, 2009-2013
List of Industrial Parks in Chengdu
Unit Price of Electricity in Chengdu Hi-Tech Industrial Development Zone
Unit Price of Water in Chengdu Hi-Tech Industrial Development Zone
Unit Price of Gas in Chengdu Hi-Tech Industrial Development Zone
International Air Transport Price Comparison between Chengdu and Shanghai & Hong Kong
International Air Transport Incidentals Comparison between Chengdu and Shanghai
List of Time and Prices for Railway Transportation from Chengdu to Shanghai/Shenzhen
Hangzhou’s GDP and YoY Growth, 2005-2013
Hangzhou’s Total Industrial Output Value and YoY Growth, 2005-2012
Hangzhou’s Total Fixed Asset Investment and YoY Growth, 2005-2013
Average Wage of On-post Employees in Hangzhou, 2009-2013
List of Development Zones in Hangzhou
Main Preferential Policies in Export Processing Zone of Hangzhou Economic and Technological Development Zone Compared with Other Regions
Unit Price of Electricity in Hangzhou Economic and Technological Development Zone
Unit Price of Water in Hangzhou Economic and Technological Development Zone
Unit Price of Gas in Hangzhou Economic and Technological Development Zone
Cost Estimation for 100,000-grade Clean Workshop in China
Distribution of Lepu Medical’s Subsidiaries
Revenue, Net Income and Gross Margin of Lepu Medical, 2009-2013
Revenue Breakdown of Lepu Medical (by Product), 2009-2013
Revenue Breakdown of Lepu Medical (by Region), 2009-2013
Gross Margin of Lepu Medical (by Product), 2009-2013
Technical Parameters of Lepu Medical’s Hoper? PTCA Balloon Dilatation Catheter
Models and Parameters of Lepu Medical’s GRIP? High Pressure Papillary Balloon Dilatation Catheter
Balloon Compliance of Lepu Medical’s Nano plus? and Partner? Stent Delivery System
Specifications of Lepu Medical’s Biguard? Stent System
Balloon Compliance of Lepu Medical’s Biguard? Stent Delivery System
Balloon Compliance of Lepu Medical’s GuReater? Stent Delivery System 
R&D Costs and % of Total Revenue of Lepu Medical, 2010-2013
Projects with Funds from IPO or Refinancing and Completion Status of Lepu Medical
Revenue and Net Income of Lepu Medical, 2012-2016E
Revenue, Net Income and Gross Margin of MicroPort, 2009-2013
Revenue Breakdown of MicroPort (by Product), 2011-2013
Revenue Structure of MicroPort (by Product), 2011-2013
Revenue Breakdown of MicroPort (by Region), 2009-2013
Revenue Structure of MicroPort (by Region), 2009-2013
Revenue from Cardiovascular Interventional Products and % of Total Revenue of MicroPort, 2011-2013
Specifications of MicroPort’s Pioneer? Balloon Dilatation Catheter
Specifications of MicroPort’s Hercules? Balloon Dilatation Catheter
R&D Costs and % of Total Revenue of MicroPort, 2009-2013
Revenue and Net Income of MicroPort, 2012-2016E
Balloon Compliance of JW Medical’s EXCEL Drug-eluting Stent Delivery System 
Features of Dalian Yinyi’s Balloon Dilatation Catheters 
Balloon Compliance of Dalian Yinyi’s Pre-dilatation Balloon Catheter Series
Balloon Compliance of Dalian Yinyi’s Post-dilatation Balloon Catheter Series
Specifications and Models of Dalian Yinyi’s Balloon Dilatation Catheters
Compliance of Neich Medical (Shenzhen)’s Sapphire? II Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s PCTA Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s Sapphire? NC High Pressure Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s Scoreflex? Dual-wire Balloon Dilatation Catheter
SCW Medicath’s PTCA Balloon Dilatation Catheters
Features and Advantages of SCW Medicath’s PTCA Balloon Dilatation Catheters
Technical Parameters of SCW Medicath’s PTCA Balloon Dilatation Catheters
Common Specifications and Models of SCW Medicath’s PTCA Balloon Dilatation Catheters
Compliance of SCW Medicath’s Standard Balloons
Compliance of SCW Medicath’s High Pressure Balloons
Main Technical Parameters of Synexmed’s Advancer? PTCA Balloon Catheter
Compliance of Synexmed’s Advancer? PTCA Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Plus? PTCA/CTO Balloon Catheter
Balloon Compliance of Synexmed’s Advancer Plus? PTCA/CTO Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Hp? High Pressure Balloon Catheter
Balloon Compliance of Synexmed’s Advancer Hp? High Pressure Balloon Catheter
Balloon Compliance of Sino Medical’s BuMA? Delivery System
Specifications and Models of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon
Balloon Compliance of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Diagram for Balloon Passing External Diameter of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Technical Parameters of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheter
Specifications and Models of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheter
Balloon Compliance of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheter
Technical Parameters of Demax Medical’s Gusta?NC Noncompliant Balloon Dilatation Catheter
Specifications and Models of Demax Medical’s Gusta?NC Noncompliant Balloon Dilatation Catheters
Balloon Compliance of Demax Medical’s Gusta?NC Noncompliant Balloon Dilatation Catheters
Revenue and Net Income of Medtronic, FY2009-FY2013
Revenue Breakdown of Medtronic (by Product), FY2009-FY2013
Revenue Structure of Medtronic (by Product), FY2009-FY2013
Revenue from Coronary Products and % of Total Revenue of Medtronic, FY2009-FY2013
Specifications of Medtronic’s Sprinter Legend Semicompliant Balloon
Specifications of Medtronic’s Sprinter OTW Semicompliant Balloon
Specifications of Medtronic’s NC Sprinter Rapid Exchange Noncompliant Balloon
Specifications of Medtronic’s Sprinter Legend OTW Semicompliant Balloon
Revenue, Net Income and Gross Margin of Boston Scientific, 2009-2013
Revenue Breakdown of Boston Scientific (by Division), 2009-2013
Revenue Breakdown of Boston Scientific (by Region), 2009-2013
Revenue from Cardiovascular Division and YoY Growth of Boston Scientific, 2009-2013
Classification, Performance and Application of Boston Scientific’s PTCA Balloon
Revenue, Net Income and Gross Margin of Abbott, 2009-2013
Revenue Breakdown of Abbott (by Product), 2009-2013
Revenue Structure of Abbott (by Product), 2009-2013
Revenue from Cardiovascular Products and % of Total Revenue, 2009-2013
Models and Specifications of Abbott’s TREK&MINI TREK Balloon
Models and Specifications of Abbott’s NC TREK Balloon
Revenue and Net Income of Terumo, FY2010-FY2013
Revenue Breakdown of Terumo (by Business), FY2010-FY2013
Revenue Breakdown of Terumo (by Region), FY2010-FY2013
R&D Costs and % of Total Revenue of Terumo, FY2010-FY2013
Revenue from Cardiovascular Business and % of Total Revenue of Terumo, FY2010-FY2013
PTCA Balloon Output and YoY Growth of Terumo, FY2009-FY2013E
Terumo’s Branch Companies in China and Their Main Businesses
Terumo’s Presence in China
Revenue, Net Income and Gross Margin of B. Braun Melsungen, 2009-2013
Revenue Breakdown of B. Braun Melsungen (by Division), 2009-2013
Revenue Breakdown of B. Braun Melsungen (by Region), 2009-2013
Models and Serial Numbers of B. Braun Melsungen’s SeQuent? Please PTCA Balloon
Models and Serial Numbers of B. Braun Melsungen’s SeQuent? Neo PTCA Balloon

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统